Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Women's health
Fierce Healthcare
FDA rolls back warning labels on HRT products for menopause
Pharmas are expected to update and reprint product labeling to remove references to risks of cardiovascular disease, breast cancer and dementia.
Anastassia Gliadkovskaya
Nov 10, 2025 1:33pm
Organon hunts for new CEO after probe exposes sales misconduct
Oct 27, 2025 10:00am
Fierce Biotech
Diabetes drug soothes brain inflammation in female mice with MS
Oct 15, 2025 6:16pm
Novartis survey explores women's feelings about breast health
Oct 7, 2025 3:30pm
Astellas attacks menopause stigma with new workplace program
Sep 5, 2025 11:02am
Daré starts push to boost interest in female sexual arousal drug
Jul 30, 2025 9:45am
